Measles nucleoprotein Antibody (83KKII) - BSA Free

• Reactivity: V-Vi
• Applications: ELISA, ICC/IF
• Clone: 83KKII
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1.0 mg/ml

Measles nucleoprotein Antibody (83KKII) - BSA Free Summary

• Immunogen: Recombinant measles NP against Edmonston strain measles virus and is known to react with all known strains of measles.
• Localization: Nuclear membrane
• Specificity: NB110-3507 recognizes the measles nucleoprotein by capture EIA.
• Isotype: IgG
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:5000 - 1:10000
  • Immunocytochemistry/ Immunofluorescence 1:10 - 1:2000

Packaging, Storage & Formulations

• Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: 0.1% Sodium Azide
• Concentration: 1.0 mg/ml
• Purity: Protein A purified

Alternate Names for Measles nucleoprotein Antibody (83KKII) - BSA Free

• Measles nucleocapsid protein
• N
• NP protein
• NP
• Nucleocapsid protein
• Nucleoprotein
• Protein N

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for Measles nucleoprotein Antibody (NB110-3507)(3)

Publications using NB110-3507

• Gillis J, Thomas K, Manoharan S et al. Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing Vaccine: X 2021-12-01 [PMID: 34622199]
• Rajaraman S, Canjuga D, Ghosh M et al. Measles virus-based treatments trigger a pro-inflammatory cascade and a treatment-specific immunopeptidome in glioblastoma Molecular Therapy - Oncolytics 2018-12-01 [PMID: 30775418] (ICC/IF, Human)
• Ungerechts, G et al. Lymphoma Chemovirotherapy: DC20-Targeted Convertase-Armed Measles Virus Can Synergize with Fludarabine. Cancer Res67: 10939-10947. 2007-01-01 [PMID: 18006839]